Funding for this research was provided by:
Norges Forskningsr&#x00E5;d (Research Council of Norway) (247730)
Science Foundation Ireland (SFI) (08/SRC/B1393, 13/IA/1959)
Text and Data Mining valid from 2018-07-18
Received: 10 April 2018
Accepted: 28 June 2018
First Online: 18 July 2018
: G.R. works at the Center of Molecular Immunology, Havana, Cuba, which develops antibodies such as 14F7 for cancer immunotherapies. G.-Å. Løset works at the drug discovery company Nextera AS.